Harnessing host immune responses to preneoplasia: promise and challenges Madhav V. Dhodapkar Opinion Paper 16 December 2004 Pages: 409 - 413
Immunotherapy for superficial bladder cancer Ellen A. M. Schenk-BraatChris H. Bangma Review 23 November 2004 Pages: 414 - 423
Comparison of antigen constructs and carrier molecules for augmenting the immunogenicity of the monosaccharide epithelial cancer antigen Tn Ella KaganGovind RagupathiPhilip O. Livingston Original Article 30 December 2004 Pages: 424 - 430
Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy Sonja OffnerArmin HekeleBirgit Kohleisen Original Article 16 October 2004 Pages: 431 - 445
Effective induction of antitumor immunity by immunization with plasmid DNA encoding TRP-2 plus neutralization of TGF-β Zheng-Cai JiaLi-Yun ZouYu-Zhang Wu Original Article 16 November 2004 Pages: 446 - 452
A phase I vaccination study with tyrosinase in patients with stage II melanoma using recombinant modified vaccinia virus Ankara (MVA-hTyr) Ralf G. MeyerCedrik M. BrittenThomas Wölfel Original Article 31 December 2004 Pages: 453 - 467
Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production Makoto KuboTakashi MorisakiMitsuo Katano Original Article 09 December 2004 Pages: 468 - 476
Tumor sensitivity to IFN-γ is required for successful antigen-specific immunotherapy of a transplantable mouse tumor model for HPV-transformed tumors Mary E. DominieckiGregory L. BeattyYvonne Paterson Original Article 06 October 2004 Pages: 477 - 488
Induction of specific human primary immune responses to a Semliki Forest virus–based tumor vaccine in a Trimera mouse model Bing NiWenda GaoYuzhang Wu Original Article 27 January 2005 Pages: 489 - 498
Reduction of the antiapoptotic protein cFLIP enhances the susceptibility of human renal cancer cells to TRAIL apoptosis Alan D. BrooksThomas J. Sayers Short Communication 22 December 2004 Pages: 499 - 505
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment Philipp SchüttUlrike ButtkereitThomas Moritz Short Communication 20 November 2004 Pages: 506 - 512
